Blocking human enterovirus 71 replication by targeting viral 2A protease.
暂无分享,去创建一个
B. Lina | J. Cortay | I. Schuffenecker | R. Montserret | N. Falah | S. Violot | V. Lelogeais | Virginie Lelogeais
[1] B. Lina,et al. Ex Vivo and In Vivo Inhibition of Human Rhinovirus Replication by a New Pseudosubstrate of Viral 2A Protease , 2011, Journal of Virology.
[2] Weizhong Yang,et al. An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of Hand Foot and Mouth Disease in Fuyang city of China , 2010, Virology Journal.
[3] I. Sam,et al. Phylogenetic designation of enterovirus 71 genotypes and subgenotypes using complete genome sequences. , 2010, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.
[4] M. Ho,et al. Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge. , 2008, Vaccine.
[5] Z. Sekawi,et al. DNA vaccine constructs against enterovirus 71 elicit immune response in mice , 2007, Genetic vaccines and therapy.
[6] N. J. Baxter,et al. Structure and Dynamics of Coxsackievirus B4 2A Proteinase, an Enyzme Involved in the Etiology of Heart Disease , 2006, Journal of Virology.
[7] C. Chiu,et al. The 1998 enterovirus 71 outbreak in Taiwan: pathogenesis and management. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[8] J. Hale,et al. Enzymatic Characterization of Refolded Human Rhinovirus Type 14 2A Protease Expressed in Escherichia coli , 1998, Journal of Virology.
[9] K. Hartmuth,et al. Purification of two picornaviral 2A proteinases: interaction with eIF-4 gamma and influence on in vitro translation. , 1993, Biochemistry.